Hypoxia-responsive calixarene-grafted self-assembled peptide hydrogel for inflammation suppression in ischemic stroke
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Neuroinflammation and Neurodegeneration Mechanisms · Nanoplatforms for cancer theranostics · Immune cells in cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Ischemic Stroke10.1016/j.amjmed.2021.07.027 ↗
2. Stroke10.1016/S0140-6736(20)31179-X ↗
3. Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association10.1161/CIR.0000000000000659 ↗
4. Review Towards clinical translation of 'second-generation' regenerative stroke therapies: hydrogels as game changers?10.1016/j.tibtech.2021.10.009 ↗
5. Wielding the Double-Edged Sword of Inflammation: Building Biomaterial-Based Strategies for Immunomodulation in Ischemic Stroke Treatment10.1002/adfm.202010674 ↗
6. The immunology of stroke: from mechanisms to translation10.1038/nm.2399 ↗
7. Multi-target approaches to CNS repair: olfactory mucosa-derived cells and heparan sulfates10.1038/s41582-020-0311-0 ↗
8. Moving beyond the glial scar for spinal cord repair10.1038/s41467-019-11707-7 ↗
9. Neuroprotective Treatments for Ischemic Stroke: Opportunities for Nanotechnology10.1002/adfm.202209405 ↗
10. Self-assembling injectable peptide hydrogels for emerging treatment of ischemic stroke10.1039/C9TB00257J ↗
11. Cryo-Shocked Platelet Coupled with ROS-Responsive Nanomedicine for Targeted Treatment of Thromboembolic Disease10.1021/acsnano.2c11865 ↗
12. Annexin V-Modified Platelet-Biomimetic Nanomedicine for Targeted Therapy of Acute Ischemic Stroke10.1002/adhm.202200416 ↗
13. Engineered Nanoerythrocytes Alleviate Central Nervous System Inflammation by Regulating the Polarization of Inflammatory Microglia10.1002/adma.202201322 ↗
14. Engineering vanadium carbide MXene as multienzyme mimetics for efficient in ischemic stroke treatment10.1016/j.cej.2022.135810 ↗
15. Bioactive Nanoenzyme Reverses Oxidative Damage and Endoplasmic Reticulum Stress in Neurons under Ischemic Stroke10.1021/acsnano.1c07205 ↗
16. Highly Effective Stroke Therapy Enabled by Genetically Engineered Viral Nanofibers10.1002/adma.202201210 ↗
17. Targeting hypoxia in cancer therapy10.1038/nrc3064 ↗
18. A Noncovalent Fluorescence Turn-on Strategy for Hypoxia Imaging10.1002/anie.201813397 ↗
19. hypoxia-activated near infrared fluorescent probe for cyclooxygenase-2 and in vivo imaging for tumor and inflammation10.1016/j.snb.2018.02.122 ↗
20. Drug in Drug: A Host-Guest Formulation of Azocalixarene with Hydroxychloroquine for Synergistic Anti-Inflammation10.1002/adma.202203765 ↗
21. Lactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas aeruginosa infected diabetic ulcer10.1038/s41467-022-33920-7 ↗
22. Integrated treatment modality of cathodal-transcranial direct current stimulation with peripheral sensory stimulation affords neuroprotection in a rat stroke model10.1117/1.NPh.4.4.045002 ↗
23. Delayed reperfusion deficits after experimental stroke account for increased pathophysiology10.1038/jcbfm.2014.197 ↗
24. A General Hypoxia-Responsive Molecular Container for Tumor-Targeted Therapy10.1002/adma.201908435 ↗
25. Recent advances in the development of nanomedicines for the treatment of ischemic stroke
26. Synthetic alpha5beta1 integrin ligand PHSRN is proangiogenic and neuroprotective in cerebral ischemic stroke10.1016/j.biomaterials.2018.09.014 ↗
27. A turn-on fluorescent probe for tumor hypoxia imaging in living cells10.1039/C5CC05518K ↗
28. Development of Azo-Based Fluorescent Probes to Detect Different Levels of Hypoxia10.1002/anie.201305784 ↗
29. Promoting Tumor Accumulation of Anticancer Drugs by Hierarchical Carrying of Exogenous and Endogenous Vehicles10.1002/sstr.202200067 ↗
30. An Antitumor Dual-Responsive Host-Guest Supramolecular Polymer Based on Hypoxia-Cleavable Azocalix[4]arene10.1002/anie.202213578 ↗
31. Enzymatic modification of self-assembled peptide structures with tissue transglutaminase10.1021/bc034017t ↗
32. Co-assembling peptides as defined matrices for endothelial cells10.1016/j.biomaterials.2009.01.033 ↗
33. Bioinspired Nanofibrous Glycopeptide Hydrogel Dressing for Accelerating Wound Healing: A Cytokine-Free, M2-Type Macrophage Polarization Approach10.1002/adfm.202006454 ↗
34. Switching the Immunogenicity of Peptide Assemblies Using Surface Properties10.1021/acsnano.6b03409 ↗
35. Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide10.1073/pnas.0505047102 ↗
36. Fusion peptide engineered "statically-versatile" titanium implant simultaneously enhancing anti-infection, vascularization and osseointegration10.1016/j.biomaterials.2020.120446 ↗
37. Dual-function injectable angiogenic biomaterial for the repair of brain tissue following stroke10.1038/s41563-018-0083-8 ↗
38. A reactive oxygen species-responsive hydrogel encapsulated with bone marrow derived stem cells promotes repair and regeneration of spinal cord injury
39. Peptide-Based Scaffolds Support Human Cortical Progenitor Graft Integration to Reduce Atrophy and Promote Functional Repair in a Model of Stroke10.1016/j.celrep.2017.07.069 ↗
40. Delivery of iPS-NPCs to the Stroke Cavity within a Hyaluronic Acid Matrix Promotes the Differentiation of Transplanted Cells10.1002/adfm.201401483 ↗
41. Dual-function hydrogels with sequential release of GSK3 beta inhibitor and VEGF inhibit inflammation and promote angiogenesis after stroke10.1016/j.cej.2021.133671 ↗
42. Fingolimod promotes angiogenesis and attenuates ischemic brain damage via modulating microglial polarization
43. Fingolimod protects against cerebral ischemia reperfusion injury in rats by reducing inflammatory cytokines and inhibiting the activation of p38 MAPK and NF-KB signaling pathways10.1016/j.neulet.2021.136413 ↗
44. ROS-responsive 18 beta-glycyrrhetic acid-conjugated polymeric nanoparticles mediate neuroprotection in ischemic stroke through HMGB1 inhibition and microglia polarization regulation
45. FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment10.2174/0929867326666190308133732 ↗
46. Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis10.1016/j.biomaterials.2015.04.060 ↗
47. FTY720 Protects Against Ischemia-Reperfusion Injury by Preventing the Redistribution of Tight Junction Proteins and Decreases Inflammation in the Subacute Phase in an Experimental Stroke Model10.1007/s12975-020-00789-x ↗
48. Fingolimod suppresses neuronal autophagy through the mTOR/p70S6K pathway and alleviates ischemic brain damage in mice
49. The Intra-nuclear SphK2-S1P Axis Facilitates M1-to-M2 Shift of Microglia via Suppressing HDAC1-Mediated KLF4 Deacetylation10.3389/fimmu.2019.01241 ↗
50. Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain10.1073/pnas.1820466116 ↗
51. An exceedingly long-lived fluorescent state as a distinct structural and dynamic probe for supramolecular association: An exploratory study of host-guest complexation by cyclodextrins10.1021/ja990626t ↗
52. Injection of Microporous Annealing Particle (MAP) Hydrogels in the Stroke Cavity Reduces Gliosis and Inflammation and Promotes NPC Migration to the Lesion10.1002/adma.201606471 ↗